LAVA Therapeutics NV Financial Flexibility Index
LAVA Therapeutics NV financial flexibility index. LAVA Therapeutics NV (LVTX) has a Financial Flexibility Index of -0.12x as of September 2025. Free cash flow of $-4.87 Million (operating CF $-4.87 Million minus capex $0.00) represents 0% of total liabilities ($39.23 Million). See LAVA Therapeutics NV (LVTX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of LAVA Therapeutics NV (2019–2024)
Financial flexibility index of LAVA Therapeutics NV from 2019 to 2024. Historical Financial Flexibility Index trend for LAVA Therapeutics NV across 6 annual periods. Check earnings quality score of LAVA Therapeutics NV to evaluate the quality of earnings relative to operating cash generation.
LAVA Therapeutics NV Financial Flexibility Index by Year (2019–2024)
LAVA Therapeutics NV financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for LAVA Therapeutics NV. For the full cash flow conversion analysis, see cash efficiency ratio of LAVA Therapeutics NV.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.37x | $-19.52 Million | $-19.54 Million | $53.09 Million | ▲ +53.0% |
| 2023 | -0.78x | $-39.55 Million | $-40.28 Million | $50.53 Million | ▼ -1070.1% |
| 2022 | 0.08x | $4.63 Million | $4.04 Million | $57.38 Million | ▲ +106.0% |
| 2021 | -1.34x | $-27.88 Million | $-28.65 Million | $20.88 Million | ▼ -95.1% |
| 2020 | -0.68x | $-8.80 Million | $-9.31 Million | $12.87 Million | ▲ +74.3% |
| 2019 | -2.66x | $-7.85 Million | $-8.62 Million | $2.95 Million | — |